News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Mark Weiner, MD

Articles by Mark Weiner, MD

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

ByJ. Sanford Schwartz, MD,Y. Richard Wang, MD, PhD,John G. F. Cleland, MD,Longlong Gao, MS,Mark Weiner, MD,Philip A. Poole-Wilson, MD,fo

June 1st 2003

Latest Updated Articles

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Published: June 1st 2003 | Updated:

Trending on AJMC

Experts, Patients Highlight Barriers to Arthritis Care Amid World Arthritis Day Observance

FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease

Medical School Diversity Declines Following Affirmative Action Repeal

Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled

Efficacy and Safety of Dupilumab in AD Across Diverse Pediatric Populations: A Q&A With Elaine Siegfried, MD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.